Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥13.7bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥26.9bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥12.8bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥291m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥502m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥309m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥1.3bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥726m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥311m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥835m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥174m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥948m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥566m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥203m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥577m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥30.9bnat 2024-09-30Cons.Assets
Total assets¥28.0bnat 2024-03-31Cons.Assets
Total assets¥29.0bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥19.3bnat 2024-09-30Cons.Liabilities
Total liabilities¥17.0bnat 2024-03-31Cons.Liabilities
Net assets / equity¥11.6bnat 2024-09-30Cons.Net assets
Net assets / equity¥10.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥10.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥6.3bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥5.2bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥6.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.6bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥921m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥622m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥327m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥10.252024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.772023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥33.282023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio31.4%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 41
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥25m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥25m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30¥2m
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentrevenue2024-04-01 → 2024-09-30¥3.5bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentrevenue external2024-04-01 → 2024-09-30¥3.5bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentsegment profit2024-04-01 → 2024-09-30¥116m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentrevenue2024-04-01 → 2024-09-30¥309m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentrevenue external2024-04-01 → 2024-09-30¥304m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥4m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentsegment profit2024-04-01 → 2024-09-30−¥3m
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue2024-04-01 → 2024-09-30¥9.8bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue external2024-04-01 → 2024-09-30¥9.8bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥21m
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentsegment profit2024-04-01 → 2024-09-30¥52m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥142m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥142m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥124m
—segment totalrevenue2024-04-01 → 2024-09-30¥13.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥13.7bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥25m
—segment totalsegment profit2024-04-01 → 2024-09-30¥289m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥21m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥21m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30¥2m
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentrevenue2023-04-01 → 2023-09-30¥2.2bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentrevenue external2023-04-01 → 2023-09-30¥2.2bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segmentsegment profit2023-04-01 → 2023-09-30−¥2m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentrevenue2023-04-01 → 2023-09-30¥225m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentrevenue external2023-04-01 → 2023-09-30¥225m
jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segmentsegment profit2023-04-01 → 2023-09-30−¥18m
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue2023-04-01 → 2023-09-30¥10.3bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue external2023-04-01 → 2023-09-30¥10.3bn
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥21m
jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segmentsegment profit2023-04-01 → 2023-09-30¥405m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥142m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥142m
jpcrp040300-q2r_E01813-000Real Estate Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥115m
—segment totalrevenue2023-04-01 → 2023-09-30¥12.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥12.8bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥21m
—segment totalsegment profit2023-04-01 → 2023-09-30¥500m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 493
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)清陽監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)光成 卓郎
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)尾関 高徳
Cpa3 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)鈴木 智喜
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration12842000000JPY
Net sales (5-year summary)CurrentYTDDuration13667000000JPY
Net sales (5-year summary)Prior1YearDuration26905000000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration726000000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration309000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration1322000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration566000000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration174000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration948000000JPY
Comprehensive income (5-year summary)Prior1YTDDuration978000000JPY
Comprehensive income (5-year summary)CurrentYTDDuration801000000JPY
Comprehensive income (5-year summary)Prior1YearDuration1557000000JPY
Net assets (5-year summary)Prior1QuarterInstant10494000000JPY
Net assets (5-year summary)CurrentQuarterInstant11648000000JPY
Net assets (5-year summary)Prior1YearInstant10930000000JPY
Total assets (5-year summary)Prior1QuarterInstant29010000000JPY
Total assets (5-year summary)CurrentQuarterInstant30927000000JPY
Total assets (5-year summary)Prior1YearInstant27951000000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration33.28
Basic earnings loss per share (5-year summary)CurrentYTDDuration10.25
Basic earnings loss per share (5-year summary)Prior1YearDuration55.77
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.300
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.314
Equity to asset ratio (5-year summary)Prior1YearInstant0.331
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration1063000000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration921000000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration2685000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-1740000000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-1349000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-2688000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration327000000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration1408000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-622000000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant5547000000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant6407000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant5258000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember17014000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember17014000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant17014000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant17014000
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember5712000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass